¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"EGF like domain"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • domain
    1. ¿µ¿ª, Á¤ÀÇ¿ª, ±¸¿ª 2. µµ¸ÞÀÎ
  • immunoglobulin domain
    ¸é¿ª±Û·ÎºÒ¸°¿µ¿ª
  • magnetic domain
    Àڱⱸ¿ª
  • glucagon-like insulinotropic peptide
    ±Û·çÄ«°ïÀ¯»çÀν¶¸°ÀÚ±ØÆéÆ¼µå
  • glucagon-like peptide
    ±Û·çÄ«°ïÀ¯»çÆéƼµå
  • insulin-like activity
    Àν¶¸°À¯»çȰ¼ºµµ
  • insulin-like growth factor
    Àν¶¸°À¯»ç¼ºÀåÀÎÀÚ
  • lichen planus-like keratosis
    ÆíÆòż±À¯»ç°¢È­Áõ
  • map like skull
    Áöµµ¸Ó¸®»À, Áöµµ¸ð¾çµÎ°³°ñ
  • pleuropneumonia-like organism
    °¡½¿¸·Æó·Å¸ð¾ç±Õ, À¯È丷Æó·Å±Õ
  • reflex like reaction
    ¹Ý»ç¸ð¾ç¹ÝÀÀ
  • rosacea-like tuberculid
    Àå¹ÌÁõ¸ð¾ç°áÇÙ¹ßÁø
  • subcutaneous panniculitis-like T-cell lymphoma
    ÇÇÇÏÁö¹æÃþ¿°À¯»çT¼¼Æ÷¸²ÇÁÁ¾
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • domain
    ¿µ¿ª
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • domain
    µµ¸ÞÀÎ, Á¤ÀDZ¸¿ª, ¿µ¿ª
  • immunoglobulin domain
    ¸é¿ª±Û·ÎºÒ¸°¿µ¿ª
  • magnetic domain
    Àڱ⿵¿ª, ÀÚ¼º¿µ¿ª
  • organic schizophrenia-like disorder
    ±âÁúÁ¤½ÅºÐ¿­º´À¯»çÀå¾Ö
  • rosacea-like eruption
    µþ±âÄÚ¹ßÁø, Àå¹Ì¿©µå¸§¹ßÁø
  • insulin-like growth factor
    Àν¶¸°À¯»ç¼ºÀåÀÎÀÚ
  • lichen planus-like keratosis
    ÆíÆòż±¸ð¾ç°¢È­Áõ
  • map like skull
    Áöµµ¸Ó¸®»À, ÁöµµµÎ°³
  • pleuropneumonia-like organism
    À¯È丷Æó·Å±Õ
  • reflex like reaction
    ¹Ý»ç¸ð¾ç¹ÝÀÀ
  • rosacea-like tuberculid
    µþ±âÄÚ°áÇÙ¹ßÁø, Àå¹Ì¿©µå¸§°áÇÙ¹ßÁø
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immunoglobulin domain
    ¸é¿ª±Û·ÎºÒ¸°¿µ¿ª.
  • IGF-I(insulin-like growth factor-I)
    Àν¶¸° À¯»ç ¼ºÀåÀÎÀÚ-1
  • Insulin-like growth factors
    Àν¶¸°¾ç(å×)¼ºÀå(à÷íþ)È£¸£¸ó
  • Lewandowskys rosacea-like eruption
    ·¹¹Ýµµºê½ºÅ° ÁÖ»ç¾ç ¹ßÁø
  • Norwalk-like agent
    ³ë¸£¿ÍÅ©¾ç ü
  • Parvovirus-like agent
    ÆÄº¸¹ÙÀÌ·¯½º¾ç º´¿øÃ¼
  • anterior pituitary-like hormone =APLH
    ÇϼöüÀü¿±¾çÈ£¸£¸ó.
  • anterior pituitary-like substance
    ³úÇϼöü Àü¿±À¯»ç¹°Áú(¡­×¾ÞÄÚªòõ).
  • fungus, yeast-like
    È¿¸ðÇüÁø±Õ, È¿¸ð¾çÁø±Õ
  • plate like atelectasis
    ÆòÆÇ¾ç ¹«±âÆó, ÆÇ¾ç ¹«±âÆó
  • pleuropneumonia-like organism
    Æó´Á¸·¿°À¯»ç º´¿øÃ¼, PPLO, ¹ÌÄÚÇö󽺸¶
  • pleuropneumonia-like organisms(p.p.l.o)
    ¿ìÈ丷Æó·Å±Õ(éÚýØØ¯øËæúж)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • epidermal growth factor (EGF)
    ÇǺÎÁõ½ÄÀÎÀÚ
  • epidermal growth factor = EGF
    Ç¥ÇÇ ¼ºÀå ÀÎÀÚ
  • domain
    µµ¸ÞÀÎ, Á¤ÀDZ¸¿ª
  • domain
    ¿µ¿ª(ÖÅæ´)
  • domain
    ¿µ¿ª(ËçËç).
  • domain
    ¿µ¿ª(çÐæ´).
  • domain structure
    ¿µ¿ª±¸Á¶
  • immunoglobulin domain
    ¸é¿ª±Û·ÎºÒ¸°¿µ¿ª.
  • magnetic domain
    ÀÚ±â(ÀÚ¼º) ¿µ¿ª
  • anterior pituitary-like hormone =APLH
    ÇϼöüÀü¿±¾çÈ£¸£¸ó.
  • anterior pituitary-like substance
    ³úÇϼöü Àü¿±À¯»ç¹°Áú(¡­×¾ÞÄÚªòõ).
  • bud like
    »õ½Ï ¸ð¾ç
  • bud-like
    Á¸ÀÕ¸ï¸ï{Àº.
  • cell like colloidal drop
    ¼¼Æ÷¾çÄÝ·ÎÀ̵å¾×Àû.
  • comet like echo
    Çý¼º¸ð¾ç ¿¡ÄÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • wart like process
    (³¶¹ÌÃæÀÇ) »ç¸¶±Íµ¹±â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • EGF
    (å²) epidermal growth factor
  • EGF-Uro
    (å²) epidermal growth factor-urogastrin
  • domain
    ¿µ¿ª(ÖÅæ´)
  • mononucleotide binding domain
    ¸ð³ë´©Å¬·¹¿ÀŸÀÌµå °áÇÕ¿µ¿ª(Ì¿ùêÖÅæ´)
  • nucleotide-binding domain
    ´©Å¬¸®¿ÀŸÀÌµå °áÇÕ¿µ¿ª(Ì¿ùêÖÅæ´)
  • protein domain
    ´Ü¹éÁú ¿µ¿ª(Ó±ÛÜòõÖÅæ´)
  • DNA-like RNA
    DNAÀ¯»ç(×¾ÞÄ) RNA
  • giant messenger-like RNA
    °Å´ë(ËÝÓÞ) À¯»çÀü·É(×¾ÞÄîîÖµ) RNA
  • glucagon-like immunoreactivity
    ±Û·çij°ïÀ¯»ç(×¾ÞÄ) ¸é¿ªÈ°¼º(Øóæ¹üÀàõ)
  • suppressible insulin-like activity
    ¾ï¾Ð °¡´É(åääâʦÒö) Àν¶¸°À¯»çȰ¼º(×¾ÞÄüÀàõ)
  • t-like RNA
    tÀÚÇü (í®úþ) RNA
  • troponin C-like protein
    Æ®·ÎÆ÷´Ñ C À¯»ç ´Ü¹éÁú(Ó±ÛÜòõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • domain
    ¿µ¿ª, µµ¸ÞÀÎ, Á¤ÀDZ¸¿ª
  • magnetic domain
    Àڱ⿵¿ª
  • bud like
    ²ÉºÀ¿À¸®°°Àº, »õ½Ï¸ð¾ç
  • comet like echo
    Çý¼º¸ð¾ç¿¡ÄÚ
  • finger like projection
    ¼Õ°¡¶ô¸ð¾çÀÇ µ¹Ãâ
  • plate like atelectasis
    ÆòÆÇ¾ç¹«±âÆó, ÆÇ¾ç¹«±âÆó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
EGF epidermal growth factor
EGFR, EGF-R epidermal growth factor receptor
EGF-URO epidermal growth factor, urogastrone
DNS Domain Name System
FQDN Fully Qualified Domain Name
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HB-EGF Heparin-Binding EGF-like growth factor
HB-EGF Heparin-binding epidermal growth factor (EGF)-like growth factor
HB-EGF Heparin binding EGF
EGF Epidermal growth factor-like
HB-EGF Heparin binding epidermal growth factor-like growth factor
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • EGF
    »óÇÇ ¼ºÀå ÀÎÀÚ
    e
  • domain structure
    ¿µ¿ª ±¸Á¶
  • salivary domain
    Ÿ¾× ¿µ¿ª
  • IGF-I : insulin like growth factor-IÀÇ ¾àÀÚ. ¼ºÀåÆÇÀÎ epiphyseal plate¿¡ ¿¬°ñ »ý¼ºÀ» Áõ°¡½ÃÄÑ »ÀÀÇ ¼ºÀåÀ» ÃËÁøÇÑ´Ù.

    IGF-II : insulin like growth factor-IIÀÇ ¾àÀÚ. ¸¹Àº Àå±â¿Í Á¶Á÷¿¡ ÀÛ¿ëÇÏ¿© ´Ü¹é ÇÕ¼º°ú DNA, RNAÀÇ ÇÕ¼ºÀ» Áõ°¡½ÃÄÑ ¼¼Æ÷ÀÇ ¼ö¿Í ¾çÀ» Áõ°¡

    Àν¶¸°¾ç ¼ºÀå ÀÎÀÚ °áÇÕ ´Ü¹éÁú
    insulinelike growth factor binding
  • bubble like cauliflower appearance
    ¹èÃß ²É ¸ð¾ç °°Àº °Åǰ
  • buffalo-like torso : ÄÚÆ¼Á¹ÀÌ °ú´ÙÇÏ°Ô ºÐºñµÉ ¶§ ÆÈ°ú ´Ù¸®ÀÇ Áö¹æ ÃàôÀº °¨¼ÒÇÏ°í ¾î±ú¿Í ¸öÅë ºÎºÐÀÇ Áö¹æ ÃàôÀº Áõ°¡ÇÏ°Ô µÇ´Âµ¥ ÀÌ·± Çö»óÀ¸·Î ÃëÇÏ°Ô µÇ´Â Ư¡ÀûÀÎ ¸ö ÇüŸ¦ ¸»ÇÑ´Ù.

    buffer

    ¿ÏÃæ¾×, ¿ÏÃæÁ¦
    1. ´Ù¸¥ È­Çй°ÁúÀÇ ³óµµ º¯È­¸¦ ¾ïÁ¦ÇÏ´Â È­Çаè. ¿¹ÄÁ´ë ¾çÀÚ °ø¿©Ã¼¿Í ¼ö¿ëü°è´Â ¼ö¼Ò À̿ ³óµµÀÇ ½ÉÇÑ º¯È­¸¦ ¾ïÁ¦ÇÏ´Â ¿ÏÃæ°è·Î ÀÛ¿ëÇÑ´Ù. ÁÖ·Î ¾à»ê, ¾à¿°±â·Î¼­, ¾î´À Á¤µµ ¹±È÷°Å³ª ¼Ò·®ÀÇ »ê ¶Ç´Â ¿°±â¸¦ ³Ö¾îµµ ¿ë¾× ¿ø·¡ÀÇ
  • cauliflower like
    ¾ç¹èÃß ²É °°Àº, ¾ç¹èÃß ²É ¸ð¾ç
    Á¼Àº ±âÀúºÎ¿Í ºñ±³Àû Å« ºñ´ë»óÀÇ ¸ð¾ç. ÆíÆòÇü À¯µÎÁ¾¿¡¼­ º¼ ¼ö ÀÖ´Ù.
  • cobblestone-like appearance
    ºÒ±ÔÄ¢ÀûÀÌ°í ±Ë¾ç¼ºÀÎ ¾ç»ó
  • corticotropin-like intermediate lobe peptide

    corticotropin-releasing factor (ºÎ½Å ÇÇÁú È£¸£¸ó À¯¸® ¿ä¼Ò, ºÎ½Å ÇÇÁú È£¸£¸ó À¯¸® ÀÎÀÚ

  • dust like particle
    ¸ÕÁö °°Àº ÀÔÀÚ
  • dust-like cataract
    ºÐÁø ¹é³»Àå
  • finger like projection
    ¼Õ°¡¶ô ¸ð¾çÀÇ µ¹Ãâ
  • fold like pattern
    Ãߺ® ¾ç»ó
  • hormone like action
    È£¸£¸ó À¯»ç ÀÛ¿ë
    ü³»¿¡ µé¾î¿Í È£¸£¸ó°ú ºñ½ÁÇÑ ¿ªÇÒÀ» ÇÏ´Â °Í.
  • human parvovirus-like agent
    »ç¶÷ ÆÄº¸ ¹ÙÀÌ·¯½º À¯»çü
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
EGF like domain Region of 30-40 amino acids containing 6 cysteines found originally in EGF and also in a range of proteins involved in cell signalling.
Examples: TGF _, amphiregulin, urokinase, tissue plasminogen activator, complement C6 C9, fibronectin, laminin (each subunit at least 13 times), nidogen, selectins. It is also found in the Drosophila gene products: Notch (36 times) Delta, Slit, Crumbs, Serrate.
(18 Nov 1997)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
EGF <growth factor> A mitogenic polypeptide initially isolated from male mouse submaxillary gland.
The name refers to the early bioassay, but epidermal growth factor is active on a variety of cell types, especially but not exclusively epithelial. Human equivalent originally named urogastrone owing to its hormone activity.
Acronym: EGF
(18 Nov 1997)
apple domain <molecular biology> A consensus sequence, composed of 90 amino acids including 6 cysteines, that forms a characteristic, vaguely apple shaped, pattern via disulphide bridges. Shared by plasma kallikrein and coagulation factor XI, both serine proteases.
(18 Nov 1997)
carboxy-terminal domain kinase <enzyme> Protein kinase that phosphorylates the c-terminal repeat domain of the largest subunit of RNA polymerase II at serine residues
Registry number: EC 2.7.1.-
Synonym: ctd kinase, hs-ctd kinase, tfiih-associated ctd kinase
(26 Jun 1999)
paired box domain <molecular biology> Conserved domain of 128 amino acids, found in several developmentally regulated proteins in Drosophila (for example paired, gooseberry, Pox), mouse and human (for example Pax, HuP1, HuP48).
(18 Nov 1997)
POU domain <molecular biology> A conserved protein domain of around 150 amino acids, composed of a 20 amino acid homeobox domain and a larger POU specific domain and so is the target of some transcription factors.
Named POU (Pit Oct Unc) after 3 such proteins: Pit 1 regulates expression of certain pituitary genes, Oct 1 and 2, that bind an octamer sequence in the promoters of histone H2A and some immunoglobulin genes and Unc 86, involved in nematode sensory neuron development.
(31 Dec 1997)
SH3 domain-containing proline-rich kinase <enzyme> A protein kinase which both phosphorylates ser and thr residues and has an sh3 domain; contains 847 amino acid residues; mol mass 92,688 da; genbank u07747
Registry number: EC 2.7.10.-
Synonym: src-homology 3 domain-containing proline-rich kinase, sprk protein, sprk gene product
(26 Jun 1999)
dinucleotide domain A structural domain in certain proteins that binds NAD+ or NADP+.
Synonym: dinucleotide domain.
(05 Mar 2000)
domain <molecular biology> Used to describe a part of a molecule or structure that shares common physico chemical features, for example hydrophobic, polar, globular, helical domains or properties for example DNA binding domain, ATP binding domain.
(18 Nov 1997)
exit domain <molecular biology> One of the two main binding sites on the ribosome molecule. The finished portion of the polypeptide being translated is attached to this site and leaves the ribosome from this site when the entire polypeptide is finished.
(09 Oct 1997)
frequency domain The expression of a function by its amplitude and phase at each component frequency, usually as determined by Fourier analysis.
(05 Mar 2000)
LIM domain Domain found in proteins required for developmental decisions. Contain 60 residue conserved, cysteine rich, repeats. Named after first 3 genes in group: Lin 11 (C. Elegans required for asymmetric division of blast cells), IsI 1 (mammalian insulin gene binding enhancer protein), mec 3 (C. Elegans required for differentiation of a set of sensory neurons).
(18 Nov 1997)
african swine fever-like viruses An unnamed, unclassified genus of DNA viruses with a single species: african swine fever virus.
(12 Dec 1998)
anterior pituitary-like hormone A glycoprotein with a carbohydrate fraction composed of d-galactose and hexosamine, extracted from the urine of pregnant women and produced by the placental trophoblastic cells; its most important role appears to be stimulation, during the first trimester, of ovarian secretion of the oestrogen and progesterone required for the integrity of conceptus; it appears to play no significant role in the last two trimesters of pregnancy, as the oestrogen and progesterone are then formed by the placenta.
Synonym: anterior pituitary-like hormone, choriogonadotropin, chorionic gonadotropic hormone, chorionic gonadotrophic hormone, placenta gonadotropin, placentagonadotropin.
(05 Mar 2000)
Artemia trypsin-like proteinase <enzyme> Cysteine proteinase involved in lipovitellin degradation
Registry number: EC 3.4.22.-
(26 Jun 1999)
box-like heart <radiology> Ebstein's anomaly, massive cardiomegaly, primarily RA enlargement
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • domain
    ¿µÅä;¿µ¿ª;ÅäÁö;°³ÀÎ ¼ÒÀ¯Áö;¹üÀ§;º¯¿ª;¿µ¿ª;ÀÚ±¸
  • eminent domain
    (¹ý)ÅäÁö ¼ö¿ë±Ç
  • magnetic domain
    (°­ÀÚ¼ºÃ¼ÀÇ) ÀÚ±¸
  • public domain
    (ÁÖ³ª Á¤ºÎÀÇ)°øÀ¯Áö(in the public domain(ÀúÀÛ±Ç Æ¯Çã±Ç ¼Ò¸ê¿¡ ÀÇÇØ)ÀÚÀ¯·Î »ç¿ëÇÒ ¼ö ÀÖ´Â)
  • public domain
    °øÀ¯Áö;ÀÚÀ¯·Î »ç¿ëÇÒ ¼ö ÀÖ´Â
  • I should like to ~
    ~ÇßÀ¸¸é ÇÑ´Ù(°â¼ÕÇÑ Ç¥Çö)
  • be like to
    ..Çϱ⠽±´Ù
  • fairy-like
    ¿äÁ¤°°Àº
  • like
    À¯»çÇÑ,-¿Í À¯»çÇÑ,ÁÁ¾ÆÇÏ´Ù
  • something like ~
    ´Ù¼Ò ~¸¦ ´àÀº,´ë·«
  • sound like ~
    ~ó·³ µé¸®´Ù,~ó·³ ´À²¸Áö´Ù
  • like
    ...´àÀº;...°°Àº;ºñ½ÁÇÑ;(°ú¿¬) ...´Ù¿î;...ÀÌ µÉ °Í °°Àº;feel ~ doing ...ÇÏ°í ½ÍÀº »ý°¢ÀÌ µé´Ù;~ nothing on earth µå¹®
  • like
    ...¿Í °°ÀÌ;...ó·³
  • like
    ±âÈ£;ÁÁ¾ÆÇÔ;~s and dislikes °¡¸®´Â °Í
  • like
    ºñ½ÁÇÑ °Í(»ç¶÷);ÇÊÀûÇÏ´Â °Í;and the ~ ...°°Àº °Í;or the ~ ...µûÀ§;the ~s of me (³·Ãß¾î) ³ª°°Àº °Í
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á